Bioengineering,
Journal Year:
2023,
Volume and Issue:
10(8), P. 950 - 950
Published: Aug. 9, 2023
In
this
study,
we
use
LSTM
(Long-Short-Term-Memory)
networks
to
evaluate
Magnetic
Resonance
Imaging
(MRI)
data
overcome
the
shortcomings
of
conventional
Alzheimer's
disease
(AD)
detection
techniques.
Our
method
offers
greater
reliability
and
accuracy
in
predicting
possibility
AD,
contrast
cognitive
testing
brain
structure
analyses.
We
used
an
MRI
dataset
that
downloaded
from
Kaggle
source
train
our
network.
Utilizing
temporal
memory
characteristics
LSTMs,
network
was
created
efficiently
capture
sequential
patterns
inherent
scans.
model
scored
a
remarkable
AUC
0.97
98.62%.
During
training
process,
Stratified
Shuffle-Split
Cross
Validation
make
sure
findings
were
reliable
generalizable.
study
adds
significantly
body
knowledge
by
demonstrating
potential
specific
field
AD
prediction
extending
variety
methods
investigated
for
image
classification
research.
have
also
designed
user-friendly
Web-based
application
help
with
accessibility
developed
model,
bridging
gap
between
research
actual
deployment.
Mobile Information Systems,
Journal Year:
2022,
Volume and Issue:
2022, P. 1 - 7
Published: June 17, 2022
Cancer
is
a
disease
caused
by
uncontrollable
cell
growth.
The
constant
subject
of
concern
due
to
unavailability
treatment
at
severe
level.
Patients
who
have
suffered
from
the
chance
getting
saved
if
this
fatal
illness
identified
in
beginning
stage.
survival
will
be
very
low
it
detected
final
stage
cancer.
As
patients
could
not
survive
their
last
stage,
cure
disease,
an
early
diagnosis
key
issue
and
vital.
For
classification
cancer,
Gaussian
Naïve
Bayes
implemented
work.
By
exerting
on
two
datasets,
algorithm
tested,
which
Wisconsin
Breast
Dataset
(WBCD)
considered
as
earliest
one
next
Lung
Dataset.
assessment
result
suggested
attained
90%
accuracy
prediction
lung
predicting
breast
98%.
Diagnostics,
Journal Year:
2022,
Volume and Issue:
12(12), P. 2975 - 2975
Published: Nov. 28, 2022
Alzheimer’s
disease
(AD)
is
a
polygenic
multifactorial
neurodegenerative
that,
after
decades
of
research
and
development,
still
without
cure.
There
are
some
symptomatic
treatments
to
manage
the
psychological
symptoms
but
none
these
drugs
can
halt
progression.
Additionally,
over
last
few
years,
many
anti-AD
failed
in
late
stages
clinical
trials
hypotheses
surfaced
explain
failures,
including
lack
clear
understanding
pathways
processes.
Recently,
different
epigenetic
factors
have
been
implicated
AD
pathogenesis;
thus,
they
could
serve
as
promising
diagnostic
biomarkers.
network
biology
approaches
suggested
effective
tools
study
on
systems
level
discover
multi-target-directed
ligands
novel
for
AD.
Herein,
we
provide
comprehensive
review
pathophysiology
better
pathogenesis
decipher
role
genetic
development
We
also
an
overview
biomarkers
drug
targets
suggest
new
identifying
drugs.
posit
that
application
machine
learning
artificial
intelligence
mining
multi-omics
data
will
facilitate
biomarker
discovery
efforts
lead
individualized
anti-Alzheimer
treatments.
Cell Reports Physical Science,
Journal Year:
2022,
Volume and Issue:
3(11), P. 101149 - 101149
Published: Nov. 1, 2022
The
capacity
of
machine-learning
methods
to
handle
large
and
complex
datasets
makes
them
suitable
for
applications
in
precision
medicine.
Current
automate
data
analysis
predict
physiological
outcomes
patients
with
various
types
clinical
inform
treatment
strategies.
In
this
perspective,
we
propose
ways
which
machine
learning
can
be
leveraged
even
further
advance
optimizing
patient
treatment.
Namely,
used
expand
feedback
control
direct
the
response
biological
systems
predictably
automatically.
This
paves
way
highly
sophisticated
treatments
that
continuously
adapt
an
individual
patient's
response.
elements
improved
using
include
sensor
analysis,
modeling,
reconfiguring
algorithm
"on
fly."
We
discuss
challenges
unique
analysis/control
systems,
existing
work,
areas
remain
underdeveloped.
IEEE Access,
Journal Year:
2023,
Volume and Issue:
11, P. 123173 - 123193
Published: Jan. 1, 2023
Alzheimer's
disease
(AD)
is
a
progressive
neurological
disorder
characterized
by
memory
loss
and
cognitive
decline,
affecting
millions
worldwide.
Early
detection
crucial
for
effective
treatment,
as
it
can
slow
progression
improve
quality
of
life.
Machine
learning
has
shown
promise
in
AD
using
various
medical
modalities.
In
this
paper,
we
propose
novel
multi-level
stacking
model
that
combines
heterogeneous
models
modalities
to
predict
different
classes
AD.
The
include
sub-scores
(e.g.,
clinical
dementia
rating
–
sum
boxes,
assessment
scale)
from
the
Disease
Neuroimaging
Initiative
dataset.
proposed
approach,
level
1,
used
six
base
(Random
Forest
(RF),
Decision
Tree
(DT),
Support
Vector
(SVM),
Logistic
Regression
(LR),
K-nearest
Neighbors
(KNN),
Native
Bayes
(NB)to
train
each
modality
(ADAS,
CDR,
FQA).
Then,
build
training
outputs
set
staking
testing
outcomes
set.
2,
three
are
produced
trains
evaluates
based
on
output
6
(RF,
LR,
DT,
SVM,
KNN,
NB)
combined
Stacking
meta-learners
evaluate
(RF).
Finally,
3,
prediction
FQA)
datasets
merged
new
dataset,
which
testing.
Training
meta-learner,
meta-learner
produce
final
prediction.
Our
research
also
aims
provide
explanations,
ensuring
efficiency,
effectiveness,
trust
through
explainable
artificial
intelligence
(XAI).
Feature
selection
optimization
Particle
Swarm
Optimization
select
most
appropriate
sub-scores.
shows
significant
potential
improving
early
diagnosis.
results
demonstrate
multi-modality
approach
outperforms
single-modality
approaches.
Moreover,
achieve
highest
performance
with
selected
features
compared
regular
ML
classifiers
full
multi-modalities,
achieving
accuracy,
precision,
recall,
F1-scores
92.08%,
92.07%,
92.01%
two
classes,
90.03%,
90.19%,
90.05%
respectively.
Bioengineering,
Journal Year:
2023,
Volume and Issue:
10(8), P. 950 - 950
Published: Aug. 9, 2023
In
this
study,
we
use
LSTM
(Long-Short-Term-Memory)
networks
to
evaluate
Magnetic
Resonance
Imaging
(MRI)
data
overcome
the
shortcomings
of
conventional
Alzheimer's
disease
(AD)
detection
techniques.
Our
method
offers
greater
reliability
and
accuracy
in
predicting
possibility
AD,
contrast
cognitive
testing
brain
structure
analyses.
We
used
an
MRI
dataset
that
downloaded
from
Kaggle
source
train
our
network.
Utilizing
temporal
memory
characteristics
LSTMs,
network
was
created
efficiently
capture
sequential
patterns
inherent
scans.
model
scored
a
remarkable
AUC
0.97
98.62%.
During
training
process,
Stratified
Shuffle-Split
Cross
Validation
make
sure
findings
were
reliable
generalizable.
study
adds
significantly
body
knowledge
by
demonstrating
potential
specific
field
AD
prediction
extending
variety
methods
investigated
for
image
classification
research.
have
also
designed
user-friendly
Web-based
application
help
with
accessibility
developed
model,
bridging
gap
between
research
actual
deployment.